Overview
Dual GLP-1/glucagon receptor agonist developed by Boehringer Ingelheim. Targets both appetite reduction and increased energy expenditure. Shows promise for both weight loss and NASH/fatty liver disease treatment.
Reported Dosing Ranges
Reference information only. Not medical advice, prescriptions, or recommendations.
Weight Loss / Metabolic Health
Dosage
0.5-6 mg
Frequency
Once weekly
Cycle Length
Ongoing months
Timing
Same day each week
Notes
Titrate up gradually over 16-20 weeks. Dual mechanism: GLP-1 reduces appetite while glucagon agonism increases energy expenditure and fat oxidation. Being studied for NASH and obesity. GI side effects are common during titration.
Reconstitution Calculator
* U-30 recommended for this dose (10.0 units)
Your Dose
Draw to
10.0units
(0.100 mL) on a U-100 syringe
Syringe Fill
U-100 insulin syringe
Reconstitution
Concentration
5.00 mg/mL
mcg per mL
5000 mcg
Per Unit (IU)
50.0 mcg
Doses Per Vial
20 doses
Storage
🌡️ Refrigerate at 2-8°C (36-46°F)
📋 Use within 28 days once reconstituted.
⏱️ Shelf life: 28 days after reconstitution